Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

U.K. Secures 30 Million Doses of Coronavirus Vaccine Candidate From Pfizer and BioNTech

TheMotleyFool

0 0

U.K. Secures 30 Million Doses of Coronavirus Vaccine Candidate From Pfizer and BioNTech

If Pfizer's (NYSE: PFE) mRNA-based coronavirus vaccine candidate ends up coming to market, it will find a ready customer in the U.K. government.

The pharmaceutical giant and its partner, Germany-based BioNTech (NASDAQ: BNTX), announced Monday that they signed a deal with the country to supply 30 million doses of the vaccine. This is pending success in clinical trials and approval from the relevant regulators.

Pfizer and BioNTech did not provide the financial details of the arrangement, but did say that its terms depend on timing and volume of doses.

Source Fool.com

Like: 0

PFE

Share